GlassScriptPhysician profile
Ginger Isom Batz
NPI 1366545873
$5,914.52
in general payments reported to CMS, 2019-2025
45 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $185 · 2021: $888 · 2022: $778 · 2023: $1,077 · 2024: $1,073 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,289.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $757.33 | 2019-2025 | Myrbetriq, Xtandi |
| Medtronic, INC. | $698.50 | 2021-2025 | Interstim, V-Loc 180 |
| Boston Scientific Corporation | $559.86 | 2019-2025 | Solyx Sis System, Axonics, General - Female Sui |
| Axonics, INC. | $509.84 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $487.32 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $294.17 | 2022-2025 | |
| Caldera Medical, INC | $276.07 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $244.57 | 2024-2025 | Provenge |
| Janssen Biotech, INC. | $206.15 | 2024-2025 | Erleada |
| Antares Pharma, INC. | $195.89 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Pfizer INC. | $119.65 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $115.72 | 2019-2023 | Xiaflex, Aveed |
| Urovant Sciences INC | $104.88 | 2022 | |
| Valencia Technologies Corporation | $104.69 | 2023-2025 | Ecoin Device Kit |
| Teleflex LLC | $90.29 | 2024-2025 | Urolift |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Isom Batz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.